LAM RESEARCH CORPORATION (LRCX) FY2024 Q3 Balance Sheet
As of 2024-03-31
Balance Sheet
As of 2024-03-31
Swipe to see the full flow
Chart details
LAM RESEARCH CORPORATION (LRCX) FY2024 Q3 Balance Sheet
Balance sheet as of 2024-03-31. The chart shows assets, liabilities and equity at that date.
- Assets
- 18,279,650,000 US dollars
- Current assets
- 12,488,436,000 US dollars
- Non-current assets
- 5,791,214,000 US dollars
- Liabilities
- 10,257,549,000 US dollars
- Current liabilities
- 4,430,089,000 US dollars
- Non-current liabilities
- 5,827,460,000 US dollars
- Equity
- 8,022,101,000 US dollars
- Cash and cash equivalents
- 5,672,232,000 US dollars
- Inventories
- 4,322,967,000 US dollars
- Accounts receivable, less allowance of $5,286 as of March 31, 2024, and $5,344 as of June 25, 2023
- 2,203,707,000 US dollars
- Prepaid expenses and other current assets
- 289,530,000 US dollars
- Investments
- 0 US dollars
- Property and equipment, net
- 2,181,741,000 US dollars
- Other assets
- 1,840,475,000 US dollars
- Goodwill
- 1,626,519,000 US dollars
- Intangible assets, net
- 142,479,000 US dollars
- Accrued expenses and other current liabilities
- 1,791,642,000 US dollars
- Deferred profit
- 1,601,733,000 US dollars
- Trade accounts payable
- 531,648,000 US dollars
- Current portion of long-term debt and finance lease obligations
- 505,066,000 US dollars
- Long-term debt and finance lease obligations, less current portion
- 4,478,385,000 US dollars
- Income taxes payable
- 832,397,000 US dollars
- Other long-term liabilities
- 516,678,000 US dollars
- Retained earnings
- 24,051,937,000 US dollars
- Additional paid-in capital
- 8,082,339,000 US dollars
- Common stock, at par value of $0.001 per share; authorized, 400,000 shares as of March 31, 2024 and June 25, 2023; issued and outstanding, 130,736 shares as of March 31, 2024, and 133,297 shares as of June 25, 2023
- 131,000 US dollars
- Preferred stock, at par value of $0.001 per share; authorized, 5,000 shares, none outstanding
- 0 US dollars
- Treasury stock, at cost; 164,423 shares as of March 31, 2024, and 161,380 shares as of June 25, 2023
- negative 23,984,518,000 US dollars
- Accumulated other comprehensive loss
- negative 127,788,000 US dollars
- Gross equity (calculated)
- 32,134,407,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
